FOR IMMEDIATE RELEASE聽|聽December 10, 2007
Five Firsts of 2007
With 2007 drawing to a close, list-making time has arrived once again. For science journalists, those aren鈥檛 just wish lists of holiday gifts, but lists of discoveries that stand out above the crowd. During a busy year of publicizing almost 300 of the 30,000 research papers published in ACS鈥檚 36 peer-reviewed scientific journals, and Chemical & Engineering News, we were impressed at the number of 鈥渇irsts鈥� noted in the Weekly PressPac and press releases.
Office of Communications (OC) science writers picked five first-of-their-kind discoveries as examples of the 鈥渇irsts鈥� socked away in the ACS PressPac and press release archives found at the ACS Press Room []. Our 鈥淔ive Firsts of 2007鈥� introduces advances in personal security, cardiovascular disease, environmental contamination and renewable energy. Please shop the PressPac and press release archives for a Santa鈥檚 sack of others, complete with links to the full-text research paper and contact information.
ARTICLE #1
The first molecular keypad lock
Journal of the American Chemical 中国365bet中文官网
How can defense or intelligence agencies safeguard the security of top-secret data protected by a computation device the size of a single molecule? With cryptography approaching that sobering new era, scientists in Israel reported development of what they term the first molecular system capable of processing password entries. Abraham Shanzer and colleagues described their 鈥渕olecular keypad lock鈥� in the Jan. 17 issue of the weekly Journal of the American Chemical 中国365bet中文官网. Electronic keypad locks long have been fixtures on home security systems and other devices that require a password.
The study, however, described a keypad lock based on molecules that fluoresce only in response to the correct sequences of three input signals.
鈥淏y harnessing the principles of molecular Boolean logic, we have designed a molecular device that mimics the operation of an electronic keypad, a common security circuit used for numerous applications in which access to an object or data is to be restricted to a limited number of persons,鈥� the researchers state. 鈥淭he development of a molecular-scale keypad lock is a particularly attractive goal as it represents a new approach to protecting information at the molecular scale.鈥� The researchers cite DNA-microdot encryption as a complementary approach, which in combination with their molecular lock might provide an unbreakable protection against forgery.
ARTICLE #2
Journal Information
Journal: Journal of the American Chemical 中国365bet中文官网
Journal Article: 鈥淎 Molecular Keypad Lock: A Photochemical Device Capable of Authorizing Password Entries鈥�
Contact:
Abraham Shanzer, Ph.D.
The Weizmann Institute of Science
Rehovot, Israel
Phone: 972-8-9343954
Fax: 972-8-9342917
Email: abraham.shanzer@weizmann.ac.il
Toward more effective treatments for aspirin-resistant patients
Journal of Proteome Research
In a first-of-its-kind study, scientists in Spain reported identification of blood proteins that seem to be involved in aspirin resistance, a condition that prevents thousands of patients from reaping aspirin鈥檚 beneficial effects in protecting against heart disease and stroke. The study appeared in the July 6 issue of ACS鈥檚 Journal of Proteome Research, a monthly journal.
Antonio J. Lopez-Farre and Carlos Macaya and colleagues described what they term the first use of a powerful technology called two-dimensional electrophoresis to study changes in different proteins present in two groups of patients with coronary artery disease, the underlying cause of most heart attacks. One group of patients was aspirin-sensitive and the other had aspirin resistance.
The researchers found increased levels of three proteins involved in the binding of vitamin D in patients with aspirin resistance. They also described additional laboratory experiments demonstrating that those proteins can inhibit aspirin鈥檚 effects in preventing blood clots. 鈥淭hese results may aid future development of more effective therapies for aspirin-resistant patients,鈥� the study concludes.
ARTICLE #3
Journal Information
Journal: Journal of Proteome Research
Journal Article: 鈥淩elationship between Vitamin D Binding Protein and Aspirin Resistance in Coronary Ischemic Patients: A Proteomic Study鈥�
Contact:
Antonio J. Lopez-Farre, Ph.D.
Hospital Clinico San Carlos
Madrid, Spain
Phone: 34-91-550-48-21
Fax: 34-91-549-47-64
Email: ajlopez.hcsc@salud.madrid.org
Explosive discovery on genetically engineered tobacco plant
Environmental Science & Technology
Tobacco may be bad for human health, but a new study reported that a genetically engineered tobacco plant may be very good for the environment. It shows promise for cleaning up soil contaminated with TNT, a widely used military explosive. The study appeared in the Aug. 15 issue of ACS鈥� Environmental Science & Technology, a semi-monthly journal.
Antonio J. Lopez-Farre and Carlos Macaya and colleagues described what they term the first use of a powerful technology called two-dimensional electrophoresis to study changes in different proteins present in two groups of patients with coronary artery disease, the underlying cause of most heart attacks. One group of patients was aspirin-sensitive and the other had aspirin resistance.
The researchers found increased levels of three proteins involved in the binding of vitamin D in patients with aspirin resistance. They also described additional laboratory experiments demonstrating that those proteins can inhibit aspirin鈥檚 effects in preventing blood clots. 鈥淭hese results may aid future development of more effective therapies for aspirin-resistant patients,鈥� the study concludes.
ARTICLE #4
Journal Information
Journal: Environmental Science & Technology
Journal Article: 鈥�Impact of Transgenic Tobacco on Trinitrotoluene (TNT) Contaminated Soil Community鈥�
Contact:
Neil C. Bruce, Ph.D.
University of York
United Kingdom
Phone: 44-1904-32877
E-mail: ncb5@york.ac.uk
鈥淲iring up鈥� enzymes for producing hydrogen in fuel cells
Nano Letters
Researchers in Colorado reported the first successful 鈥渨iring up鈥� of hydrogenase enzymes. Those much-heralded proteins are envisioned as stars in a future hydrogen economy where they may serve as catalysts for hydrogen production and oxidation in fuel cells. Their report, describing a successful electrical connection between a carbon nanotube and hydrogenase, appeared in the Nov. issue of ACS' Nano Letters, a monthly journal.
In the study, Michael J. Heben, Paul W. King, and colleagues explain that bacterial enzymes called hydrogenases show promise as powerful catalysts for using hydrogen in fuel cells, which can produce electricity with virtually no pollution for motor vehicles, portable electronics, and other devices. However, scientists report difficulty incorporating these enzymes into electrical devices because the enzymes do not form good electrical connections with fuel cell components. Currently, precious metals, such as platinum, are typically needed to perform this catalysis.
The researchers combined hydrogenase enzymes with carbon nanotubes, submicroscopic strands of pure carbon that are excellent electrical conductors. In laboratory studies, the researchers demonstrated that a good electrical connection was established using photoluminescence spectroscopy measurements. These new 鈥渂iohybrid鈥� conjugates could reduce the cost of fuel cells by reducing or eliminating the need for platinum and other costly metal components, they say.
ARTICLE #5
Journal Information
Journal: Nano Letters
Journal Article: 鈥淲iring-Up Hydrogenase with Single-Walled Carbon Nanotubes鈥�
Contact:
Michael J. Heben, Ph.D.
Energy Sciences
National Renewable Energy Laboratory
Golden, Colorado 80401
Phone: 303-384-6641
Fax: 303-384-6432
Email: Michael_heben@nrel.gov
Paul W. King, Ph.D.
Energy Sciences
National Renewable Energy Laboratory
Golden, Colorado 80401
Phone: 303-384-6277
Fax: 303-384-6150
Email: Paul_king@nrel.gov
Toward a faster prenatal test for Down syndrome
Analytical Chemistry
Scientists in California reported an advance toward rapid testing for pre-natal detection of Down syndrome and other birth defects that involve an abnormal number of chromosomes.
In a study that appeared in the Oct. 1 issue of ACS鈥� journal Analytical Chemistry, Stanford University bioengineering professor and Howard Hughes Medical Institute researcher Stephen R. Quake and his graduate student H. Christina Fan point out that most existing pre-natal tests depend on a technique termed karyotyping. It requires a two-week wait for anxious parents, while cells taken with amniocentesis or chorionic villus sampling are grown in laboratory culture and analyzed.
Laboratory studies with the new method produced accurate results within two hours. The test is a variation of the famed polymerase chain reaction (PCR) 鈥� the basis of the genetic engineering revolution 鈥� which produces thousands of identical copies of minute samples of DNA.
Using a technique known as the digital polymerase chain reaction, Quake and Fan replicated DNA from two cultures of cells growing in the laboratory. One consisted of a normal human cell line and the other had human cells with the Down variant. The digital
PCR process allowed the researchers to count DNA molecules from the samples, substituting for the two-week cell culture process traditionally needed to produce enough DNA for karyotyping. With the precision derived from counting individual DNA molecules, researchers then were able to move ahead without delay and determine which samples had the extra chromosome that indicates Down syndrome.
*The research in this release is from a copyrighted publication, and stories must credit either the journal by name or the American Chemical 中国365bet中文官网.
Journal Information
Journal: Analytical Chemistry
Journal Article: 鈥淒etection of Aneuploidy with Digital Polymerase Chain Reaction鈥�
Contact:
Stephen R. Quake, Ph.D.
Department of Bioengineering
Stanford University
Howard Hughes Medical Institute
Stanford, CA 94305
Phone: 650-736-1809
Fax: 650-736-1961
Email: quake@stanford.edu